Lissa Eggermont
Doctoral fellow - Biomarkers in Cancer Unit – UGent
Principal investigator: prof. Sylvie Rottey (MD, PhD) and dr. Tijl Vermassen (PhD)
Research focus
My research topic is glycomics.
Prostate cancer is a very common cancer in men. Despite improved imaging and surgery, there are no good biochemical biomarkers available that can distinguish prostate cancer from benign prostate disease, nor that can distinguish indolent from more aggressive prostate cancers. In the recent years, it has become well accepted that altered N-glycosylation is a hallmark of cancer progression, including in prostate cancer. Our research group demonstrated that these altered N-glycosylation patterns hold promise as potential biomarkers for diagnosis and prognosis of prostate cancer. Currently, we are exploring the use of N-glycosylation as diagnostic biomarker for prostate cancer by the use of capillary electrophoresis (collaboration with VIB-UGent [unit Nico Callewaert]). The objective of this research is to develop and validate a urinary biomarker that we can implement in daily practice for the diagnosis of (aggressive) prostate cancer.
Contact & links
- Address: Department Medical Oncology, UZ Gent, Corneel Heymanslaan 10, entrance 50, route 535, 9000 Gent
- Callewaert lab (CMB VIB-UGent)
- Lissa Eggermont is interested to receive invitations for presentations or talks.